- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01215682
Vitamin D Supplementation and Upper Respiratory Tract Infections in Adolescent Swimmers
Vitamin D Supplementation, Upper Respiratory Tract Infections, Immune and Physical Functions in Adolescent Swimmers
Background: The medical and economic burden of upper respiratory tract infections (URTIs) is extremely high, while prevention and treatment options are limited. Therefore, there is a constant need for new methods in order to significantly decrease such morbidity. Extensive evidence shows that vitamin D is associated with respiratory health, including in the prevention and treatment of URTIs. Competitive swimmers have a high prevalence of URTIs, and can serve as a model for research in this field.
The study hypothesis is that vitamin D supplementation to young swimmers with low vitamin D levels will reduce the frequency, length, and severity of URTIs and their accompanying functional impairment, while improving cellular immune function and physical function.
Methods: After screening 100 competitive adolescent swimmers to obtain ~60 with low serum levels of vitamin D, this study group will be randomized to receive either vitamin D supplementation (2000 IU/d) or placebo, given in a double blinded fashion for three months. Participants will fill a daily questionnaire regarding frequency, length and severity of URTIs symptoms and functional impairment. Blood will be drawn to evaluate changes in vitamin D status (25(OH)D) and immune function among study participants at the beginning of the study and after supplementation. Physical function on land and in water will also be assessed.
Expected results: Increase in serum 25(OH)D levels following supplementation will significantly decrease the frequency, length and severity of URTI's and their functional impairment, while enhancing the cellular immune system function and physical capacity.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Haifa, Israel
- Maccabi Haifa Swimming Club
-
Herzlyia, Israel
- Bnei Herzlyia Swimming Club
-
Hod Hasharon, Israel
- Hod Hasharon Swimming Club
-
Maccabim, Israel
- Maccabim-Reut Swimming Club
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- members of swimming team
- training at least 15 hours/week
- low vitamin D plasma levels (<30 ng/ml)
- signed consent forms
Exclusion Criteria:
- chronic health conditions
- taking prescription medications
- taking diet supplementations
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Cuadruplicar
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Comparador de placebos: placebo
|
sweetened water
|
Comparador activo: vit D
|
2000 IU/day of vitamin D3 as a once-daily dose
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
URI frequency
Periodo de tiempo: 3 months
|
URI frequency will be measured in both groups, starting 4 weeks after initiating the suplementation.
Analysis will also assess differences by sex or initial vitamin D levels, as well as by immune function changes.
|
3 months
|
URI duration
Periodo de tiempo: 3 months
|
URI duration will be measured in both groups, starting 4 weeks after initiating the suplementation.
Analysis will also assess differences by sex or initial vitamin D levels, as well as by immune function changes.
|
3 months
|
UTI severity
Periodo de tiempo: 3 months
|
URI severity will be measured in both groups, starting 4 weeks after initiating the suplementation.
Analysis will also assess differences by sex or initial vitamin D levels, as well as by immune function changes.
|
3 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
plasma vitamin D levels
Periodo de tiempo: 3 months
|
3 months
|
|
immune system function
Periodo de tiempo: 3 months
|
T-cell receptor excision circles (TREC), T cell receptor repertoire, B-cell receptor excision circles (BREC).
Comparison will be made with changes in vitamin D levels and with URI characteristics.
|
3 months
|
physical function
Periodo de tiempo: 3 months
|
absence from school or training, land and swimming fitness tests.
Comparison will be made with changes in vitamin D levels.
|
3 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Gal Dubnov-Raz, MD MSc, Sheba Medical Center
- Investigador principal: Naama W Constantini, MD, Hadassah Medical Organziation
- Investigador principal: Avner Cohen, MD, Clalit Health Services
- Investigador principal: Raz Somech, MD PhD, Sheba Medical Center
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- SHEBA-10-7762-GDR-CTIL
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre vitamin D
-
Aalborg UniversityAalborg University Hospital; CCBR Aalborg A/S, Aalborg, DenmarkTerminadoMigraña según los criterios de la International Headache Society (IHS) (ICHD-II)Dinamarca
-
Royal Prince Alfred Hospital, Sydney, AustraliaTerminadoColonoscopiaAustralia
-
Rhode Island HospitalVirtually Better, Inc.TerminadoSalud mental | Virus de inmunodeficiencia humanaEstados Unidos
-
GlaxoSmithKlineTerminadoInfluenza HumanaEstados Unidos, Bélgica
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Aún no reclutando
-
University Medical Center GroningenMaastricht University Medical Center; UMC Utrecht; Academisch Medisch Centrum -... y otros colaboradoresTerminadoInsuficiencia cardiacaPaíses Bajos
-
Daewoong Pharmaceutical Co. LTD.Aún no reclutando
-
University of AarhusNovo Nordisk A/S; Aarhus University Hospital; AP Moeller Foundation; Danish Diabetes...ReclutamientoEnvejecimiento | Trastorno del metabolismo | Cetonemia | Trastorno muscularDinamarca
-
Heartseed Inc.ReclutamientoInsuficiencia cardiaca | Enfermedad isquémica del corazónJapón
-
Abbott Medical DevicesTerminadoInsuficiencia cardiacaEstados Unidos